IMPORTANCE Surgical skin markers are used off-label to mark human saphenous veins (HSVs) to maintain orientation before implantation as aortocoronary or peripheral arterial bypass grafts. These surgical skin markers impair functional responses of the HSV tissue.
RESULTS
CONCLUSIONS AND RELEVANCE Treatment with FCF did not impair endothelial or smooth muscle function in HSVs. Brilliant blue FCF enhanced endothelial-dependent relaxation, restored smooth muscle function, and prevented intimal hyperplasia in HSVs in organ culture. These pharmacological properties of FCF may be due to P2X 7 receptor or pannexin channel inhibition. Brilliant blue FCF is an alternative, nontoxic marking dye that may improve HSV conduit function and decrease intimal hyperplasia. While incompletely understood, intimal hyperplasia results from a cascade of molecular and cellular events that are triggered by injury. This process leads to pathologic narrowing of the vessel lumen, graft stenosis, and ultimately graft failure. 2 4 Surgical skin markers contain isopropyl alcohol as a solvent, which is injurious to the graft. 5 Heparinized normal saline (0.9% sodium chloride solution) is commonly used to store grafts before implantation. This solution is nonbuffered and has a pH of approximately 6, which may cause further harm to the conduit (C.B. and J.C.-F., unpublished observations, 2014). Given that saphenous vein is an autologous transplanted organ, harvest and preparation manipulations should be designed to minimize injury, which may lead to reduced intimal hyperplasia and improved clinical outcomes. 6, 7 In this investigation, a water-soluble dye was examined as a potential intervention to mitigate preparation-induced vein graft injury. Brilliant blue dye 1 ([brilliant blue FCF [for food coloring]; hereinafter, FCF) is a food dye that is structurally related to brilliant blue G, which is an antagonist of the purinergic P2X 7 receptor 8 and the pannexin hemichannel (Panx1). 9 We determined the effect of FCF on endothelial and smooth muscle function in human saphenous veins (HSVs). Brilliant blue FCF enhanced endothelial function and restored smooth muscle function, suggesting that it had pharmacological properties via inhibition of vascular P2X 7 receptors and of Panx1.
10,11

Methods
Procurement of HSVs
After written informed consent and approval by the institutional review boards of Vanderbilt University and the Veterans Affairs Tennessee Valley Healthcare System, 42 HSV segments were collected from patients undergoing coronary artery bypass grafting procedures. Vein segments were collected immediately following surgical harvest (unmanipulated [UM]) and after typical intraoperative manipulations, including hydrostatic distension with a handheld syringe, marking with a surgical skin marker, and storage in room temperature heparinized saline (10 U/mL) (HS) or heparinized PlasmaLyte (HP), both from Baxter, at the surgeon's discretion, until implantation (after manipulation [AM]). Segments were transported to the laboratory for immediate testing.
Procurement of Rat Inferior Venae Cavae
All chemicals were purchased from Sigma-Aldrich unless otherwise specified. Inferior venae cavae (IVCs) were collected from 7 euthanized Sprague-Dawley rats. Animal procedures followed study protocols approved by the Vanderbilt University Institutional Animal Care and Use Committee and adhered to National Institutes of Health guidelines for care and use of laboratory animals. Immediately after euthanasia, the abdominal IVC was isolated via an incision along the midabdomen, placed in cold transplant harvest buffer (100mM potassium lactobionate, 25mM monopotassium phosphate, 5mM magnesium sulfate, 30mM raffinose, 5mM adenosine, 3mM glutathione, 1mM allopurinol, 50 g/L of hydroxyethyl starch, and pH 7.4), and transported to the laboratory for immediate testing.
Physiologic Responses of HSVs
Rings approximately 1.0 mm in width were cut from HSV segments after dissection free from connective tissue and fat.
Rings from UM-HSV segments were suspended in a muscle bath immediately (control) or stored in HP with or without 50μM FCF. Fifty micromolar is the approximate concentration of FCF in the cellular microenvironment of a 1-mm ring marked topically with a 2.6mM FCF solution and placed in 4 mL of HP for 2 hours (as determined by a calorimetric assay).
In other experiments, AM-HSV segments were left untreated or marked with a 2.6mM solution of FCF to approximate clinically applicable conditions. Tissues were suspended in the muscle bath containing a bicarbonate buffer (120mM sodium chloride, 4.7mM potassium chloride, 1.0mM magnesium sulfate, 1.0mM monosodium phosphate, 10mM glucose, 1.5mM calcium chloride, 25mM sodium bicarbonate, and pH 7.4) and equilibrated with 95% oxygen-5% carbon dioxide at 37°C. Tissues were sequentially stretched to the optimal resting tension (approximately 1g), stretched 3 to 4 times the resting tension to determine the passive lengthtension relationship, 12,13 and followed by maintenance at 1g
for an additional 1 hour. Force measurements were obtained using a force transducer (model 159901A; Radnoti) interfaced with a data acquisition system (16/30; PowerLab) and a software program (Chart; AD Instruments).
The maximal response to 110mM potassium chloride (with equimolar replacement of sodium chloride in bicarbonate buffer) was determined, which was equivalent to an initial tension of 4g. Smooth muscle functional viability was determined by repeatedly contracting the tissues with 110mM potassium chloride until consistent maximal force was generated. The UM-HSV rings generating stress of 0.025 × 10 5 N/m
Physiologic Responses of Rat IVCs
Rat IVC rings approximately 2.0 mm in width were cut, suspended in the muscle bath, and equilibrated as described above for HSVs. The rings were then contracted with 110mM potassium chloride to determine maximal contractile response. Next, functionally viable rat IVC rings were left untreated or treated with 50μM FCF, 50μM periodate-oxidized adenosine triphosphate (oATP) (an irreversible P2X 7 antagonist), or probenecid (a Panx1 inhibitor, 0.5mM and 2mM; Life Technologies) for 30 minutes before contraction with 100μM 2′(3′)-O-(4-benzoyl) benzoyl-adenosine-5′-triphosphate (BzATP) (a prototypical P2X 7 receptor agonist). The BzATP-induced contraction was expressed as the percentage of maximal potassium chlorideinduced contraction.
Organ Culture
Rings (1-2 mm in width) were cut from HSV segments (UM and AM). Two rings from each sample were placed in 10% neutral buffered formalin (Fisher Scientific) to measure basal (preculture) intimal thickness. Additional rings were placed in organ culture as described previously 15 in the absence or the presence of 50μM FCF. This method of vein culture has been validated as an ex vivo model system of the changes occurring in vivo and has been used previously in our laboratory. 4 
Statistical Analysis
Contractile responses were defined by stress. The stress was calculated using force generated by tissues as follows:
where Area = [Wet Weight (mg)/Maximal Length (mm)]/1.055. Data were reported as mean (SEM) responses. Paired t tests or 1-way analysis of variance (ANOVA) with Tukey posttests between treatment groups were conducted to determine the significance (P value) of experiments. P < .05 was considered statistically significant. The P value for 1-way ANOVA analysis was computed from the F ratio (F n,n′ , where F represents the ratio between-column to within-column mean squares, and n and n′ represent the respective degrees of freedom used to calculate the mean squares). 
Results
Endothelial and Smooth
BzATP-Induced Contraction of Rat IVCs Treated With FCF and Probenecid
The BzATP induced contractions in rat IVCs (mean, 14.8% [2.2%] of maximal potassium chloride response) ( Figure 3A) . 
Research Original Investigation Brilliant Blue FCF
Back-table manipulation of HSVs, including handheld syringe distension, marking with a surgical skin marker for orientation, and storage in HS led to significantly impaired endothelial and smooth muscle function compared with UM segments.
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Our group previously showed that the isopropyl alcohol in surgical skin markers is injurious to the conduit and may contribute to vein graft failure. 5 In this study, we investigated the use of a water-soluble dye, brilliant blue FCF, to mark HSV segments. This dye was not only nontoxic ( Figure 1A ) but also fully enhanced endothelial function present in UM-HSVs ( Figure 1B) . Moreover, 42% (5 of 12) of HSV segments that had almost no smooth muscle functional responses and would otherwise be considered nonviable showed significant improvement in contractile responses after treatment with FCF ( Figure 2 ). Taken together, these data suggest that the FCF dye has pharmacological properties that may be beneficial to the conduit. Brilliant blue FCF is structurally similar to brilliant blue G, a dye shown to have pharmacological properties by restoring function and diminishing cell death after stretch injury in rat spinal cord. 19 Brilliant blue G antagonizes the P2X 7 receptor, a member of the P2X purinergic receptor family. These receptors are transmembrane, ligand-gated ion channels that are activated by extracellular ATP and its analogues. 20 In the presence of agonists, P2X 7 receptor activation led to formation of large-pore complexes contributing to ion fluxes and cellular cytolysis. 21 In addition, P2X 7 receptors have been implicated in the regulation of vascular tone, modulation of inflammatory mediators within the vessel wall, and vascular smooth muscle and endothelial cell injury. 22 von Albertini and colleagues 23 demonstrated the association of purinergic signaling via P2X 7 receptors with nuclear factor κB activation, inflammation, and endothelial cell apoptosis. It is conceivable that vein injury during intraoperative manipulation leads to local release of extracellular ATP, 24 thereby activating P2X 7 receptors and contributing to tissue dysfunction. Therefore, it is likely that FCF treatment enhanced endothelial function in HSV grafts via inhibition of P2X 7 receptors. In addition, inhibition of purinergic signaling by FCF may have prevented P2X 7 receptor activationinduced smooth muscle cell lysis, restoring smooth muscle function. BzATP-induced contraction in rat IVCs ( Figure 3B ), suggesting that blockade of Panx1 interferes with P2X 7 receptor activation. Ligands to the P2X 7 receptor also inhibit Panx1 9 ; FCF has also been shown to selectively inhibit Panx1. 27 Given that elevated extracellular ATP is a hallmark of tissue damage, 22, 28, 29 it is plausible that FCF modulates ATP release and ameliorates graft injury through inhibition of P2X 7 receptor-induced Panx1 activation. In blood vessels, the fragile endothelial monolayer is essential in preventing exposure of the medial layer to serum growth factors, producing nitric oxide that inhibits platelet activation and smooth muscle cell proliferation, and promoting decreased thrombosis and inflammation.
30 Intimal hyperplasia has been associated with decreased endothelial-dependent relaxation in HSVs. 17 Smooth muscle injury leads to migration, proliferation, and production of extracellular matrix proteins, which contribute to intimal hyperplasia. 31 Our group has previously shown that intraoperative manipulation of the grafts promotes intimal thickening in an organ culture model.
In this study, we showed that FCF prevents intimal thickening in HSVs, both UM and AM, in the organ culture model (Figure 4) . Taken together, these data suggest that impaired endothelial and smooth muscle functions are associated with increased intimal thickening ex vivo. These data also suggest that ATP may be released during preparation-induced injury and activate the P2X 7 and Panx1 channels ( Figure 5) . These receptors may be implicated in endothelial and smooth muscle injury and the development of intimal hyperplasia in saphenous vein grafts via downstream signaling of the P2X 7 receptor. Therefore, the use of FCF during vein graft preparation may attenuate activation of these purinergic signaling pathways, vascular injury, and the development of intimal hyperplasia.
A limitation of this investigation is that it relied primarily on studies of vascular function. However, functional studies of intact tissues have advantages over cultured cells in that they represent the complex biology associated with the interactions of the components of the tissues. In addition, while the organ culture model contains serum, it lacks in vivo elements (pressure, flow, and exposure to blood components) that are associated with arterialization. Further studies are needed to determine whether FCF prevents intimal hyperplasia and vein graft failure in grafts implanted in vivo.
Conclusions
Because HSV is an autologous transplanted organ, it is likely that addressing and preventing injury during the time that the graft is ex vivo would improve vein graft patency. The period of ex vivo manipulation is an optimal time for targeting therapeutics to prevent vein graft failure because the therapeutic can be delivered directly to the conduit, limiting systemic administration and toxic effects. Moreover, to enhance evaluation of new clinical therapeutics that may prevent intimal hyperplasia, standardizing graft preparation with careful techniques to preserve conduit viability and function is essential. In this investigation, we showed that FCF not only serves as an alternative to the current off-label use of surgical skin markers but also enhances physiologic function. We also demonstrated that current vein graft preparation techniques promote intimal hyperplasia, which can be reduced by FCF treatment. Further investigation is warranted to determine whether antagonism of the P2X 7 receptor by FCF during graft preparation will improve graft patency. 
